These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5917835)

  • 1. Low-molecular-weight dextran in acute myocardial infarction.
    Borchgrevink CF; Enger E
    Br Med J; 1966 Nov; 2(5524):1235-8. PubMed ID: 5917835
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dextran 40 on hemorheological factors during the course of acute myocardial infarction. A preliminary report.
    Ditzel J; Bang HO; Thorsen N
    Bibl Anat; 1969; 10():132-6. PubMed ID: 4948068
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of low-molecular dextran on the hemodynamics and activity of serum enzymes in the early periods of myocardial infarction].
    Himmel A; Tkaczewski W; Gebicki L
    Pol Tyg Lek; 1969 Oct; 24(45):1717-20. PubMed ID: 5364152
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with low molecular weight dextran in acute myocardial infarction.
    Langsjoen PH
    J Miss State Med Assoc; 1969 Nov; 10(11):499-502. PubMed ID: 5352795
    [No Abstract]   [Full Text] [Related]  

  • 5. [LOW MOLECULAR DEXTRAN TREATMENT IN MYOCARDIAL INFARCT].
    LINDEN L
    Sven Lakartidn; 1964 Jul; 61():2300-5. PubMed ID: 14178283
    [No Abstract]   [Full Text] [Related]  

  • 6. [Management of acute myocardial infarct using low molecular dextran].
    Reutter FW; Mazzoni S; Wegmann T
    Schweiz Med Wochenschr; 1968 Aug; 98(33):1218-21. PubMed ID: 5682096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of serum cholesterol in myocardial infarct].
    Meyer HJ
    Z Kreislaufforsch; 1970 Dec; 59(12):1124-34. PubMed ID: 5502619
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the prognosis of myocardial infarction.
    Hinohara S
    Jpn Circ J; 1967 Nov; 31(11):1575-9. PubMed ID: 5630876
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of fibrinolysin therapy in acute myocardial infarction.
    Richter IH; Epstein S; Cliffton E
    Angiology; 1969 Feb; 20(2):95-101. PubMed ID: 4236973
    [No Abstract]   [Full Text] [Related]  

  • 10. [On thrombolytic treatment of a recent heart infarction. 3. Comprehensive summary including enzyme evaluation].
    Körtge P; Praetorius F; Schneider B; Heckner F; van de Loo J; Pezold FA; Poliwoda H; Schmutzler R; Zekorn D
    Dtsch Med Wochenschr; 1967 Sep; 92(35):1546-51. PubMed ID: 6054317
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of cases with acute myocardial infarction to infusion with low-molecular weight dextran (lomodex).
    Lal HB; Caroli RK; Malik RN; Sengupta D; Basumalik SN; Warrik HP; Behl AN
    Indian J Med Sci; 1968 Apr; 22(4):214-9. PubMed ID: 4875866
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of anticoagulant therapy in myocardial infarction.
    Hashimoto Y
    Jpn Circ J; 1967 Oct; 31(10):1415-24. PubMed ID: 5630867
    [No Abstract]   [Full Text] [Related]  

  • 13. Group II. Acute myocardial infarction treated with low molecular weight dextran. (Lomodex-Tata Fison & Co., ltd). A controled study alongwith some observations on its effects on some laboratory parameters.
    Lal HB; Caroli RK
    Indian J Med Res; 1968 Jul; 56(7 Suppl):1116-9. PubMed ID: 4881517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the activity of transaminases during long-term treatment with anticoagulants after myocardial infarct].
    Büsch F
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2128-31. PubMed ID: 4650681
    [No Abstract]   [Full Text] [Related]  

  • 15. [Personal experience with low molecular weight dextran, "Rheomacrodex", in the treatment of acute vascular obstructions].
    Fabra Jiménez L
    Rev Esp Cardiol; 1966 Apr; 19(2):189-97. PubMed ID: 5945474
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolytic treatment of acute myocardial infarction. A preliminary report.
    Heikinheimo R; Ahrenberg P; Honkapohja H; Iisalo E; Kallio V; Konttinen Y; Leskinen O; Mustaniemi H; Reinikainen M; Siitonen L
    Adv Cardiol; 1970; 4():241-5. PubMed ID: 5493446
    [No Abstract]   [Full Text] [Related]  

  • 17. The thrombolytic therapy of recent myocardial infarction. 3. Overall assessment and evaluation of enzyme studies.
    Körtge P; Praetorius F; Schneider B; Heckner F; Van de Loo J; Pezold FA; Poliwoda H; Schmutzler R; Zekorn D
    Ger Med Mon; 1968 Mar; 13(3):111-6. PubMed ID: 5656864
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of reducing blood viscosity in acute myocardial infarction.
    Langsjoen PH
    Bibl Anat; 1973; 11():180-4. PubMed ID: 4596759
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sodium 3,4-5-trimethoxy-benzoyl-epsilon-amino-caproate (C-tre) in the treatment of acute myocardial infarct].
    Longhini I; Razzaboni G; Gramolini C; Casoni T; Ferracioli GF
    Minerva Med; 1973 Aug; 64(59):3080-90. PubMed ID: 4742648
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombolytic therapy of the fresh myocardial infarct].
    Sailer S; Wehrschütz E; Tilz GP
    Wien Med Wochenschr; 1968 Mar; 118(13):283-5. PubMed ID: 5672071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.